[{"id":"fd27eba5-070d-465c-9dd7-90afaae4e124","acronym":"PV-10-NET-01","url":"https://clinicaltrials.gov/study/NCT02693067","created_at":"2021-02-11T16:53:11.341Z","updated_at":"2024-07-02T16:35:56.153Z","phase":"Phase 1","brief_title":"A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver","source_id_and_acronym":"NCT02693067 - PV-10-NET-01","lead_sponsor":"Provectus Biopharmaceuticals, Inc.","biomarkers":" SSTR","pipe":" | ","alterations":" SSTR Expression","tags":["SSTR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SSTR Expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Provecta (rose bengal sodium)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 07/01/2016","start_date":" 07/01/2016","primary_txt":" Primary completion: 09/01/2021","primary_completion_date":" 09/01/2021","study_txt":" Completion: 09/01/2023","study_completion_date":" 09/01/2023","last_update_posted":"2023-02-08"}]